Schering-Plough To Fill Biomarker Gap With Singapore Research Center
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - Schering-Plough recently launched the Translational Medicine Research Center in Singapore, hoping to capitalize on the country's biomedical infrastructure and collaboration opportunities, to address a "big gap" in the company's biomarker development
You may also be interested in...
Singapore Offers Public Funds To Bridge Valley Of Death, But Can It Last? – BioMedical Asia
SINGAPORE - There is no dearth of research programs - the trouble is capital has evaporated and risk appetite is anorexic, BioMedical Asia speakers said in Singapore March 17
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).